Dose Escalation Study of a PD1-LAG3 Bispecific Antibody in Patients With Advanced and/or Metastatic Solid Tumors
Hoffmann-La Roche
Hoffmann-La Roche
M.D. Anderson Cancer Center
AstraZeneca
Genmab
Mayo Clinic
BioNTech SE
STORM Therapeutics LTD
Neonc Technologies, Inc.
Hummingbird Bioscience
Bristol-Myers Squibb
Arvinas Inc.
Aulos Bioscience, Inc.
M.D. Anderson Cancer Center
Essen Biotech
Essen Biotech
University of California, Davis
Beijing Tide Pharmaceutical Co., Ltd
M.D. Anderson Cancer Center
Second Life Therapeutics
Onchilles Pharma Inc
M.D. Anderson Cancer Center
Linnaeus Therapeutics, Inc.
GV20 Therapeutics
Transgene
DualityBio Inc.
Revolution Medicines, Inc.
University of Pittsburgh
University of Arizona
Hadassah Medical Organization
7 Hills Pharma, LLC
Obsidian Therapeutics, Inc.
Incyte Corporation
Palleon Pharmaceuticals, Inc.
Incyte Corporation
Incyte Corporation
Cancer Research UK
NuCana plc
Marengo Therapeutics, Inc.
NGM Biopharmaceuticals, Inc
Rapa Therapeutics LLC
Xynomic Pharmaceuticals, Inc.
Syndax Pharmaceuticals
BioAtla, Inc.
OncoResponse, Inc.
Purple Biotech Ltd.
Aminex Therapeutics, Inc.
Iovance Biotherapeutics, Inc.
National Cancer Institute (NCI)
Simcha IL-18, Inc.
Salubris Biotherapeutics Inc